By James A. Lyons
Independent voices from the TWT Communities
A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of dying from side effects linked to it is higher than the risk for patients on chemotherapy alone.
More Stories →
